Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR
Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post
JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant: 7 January 2022 - GOV.UK
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study - The Lancet Respiratory Medicine
moderna | Malheur County Health Department
Are COVID-19 vaccine boosters needed? | Virology Blog
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
How Long Does COVID Immunity Last After a Booster Shot?
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
COVID-19 Vaccine Boosters at VA Long Beach and New Website
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
CDC - Is it time for your COVID-19 booster? Everyone ages... | Facebook
Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England | Nature Medicine
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Israel hopes boosters can avert new lockdown as Covid vaccine efficacy fades
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
COVID-19 vaccine breakthrough infections | Science
Coronavirus: Covid Updates: Colorado Approves Booster Shot for All Adults - The New York Times
Booster needed to neutralize the fast-spreading variant | World Economic Forum
